trending Market Intelligence /marketintelligence/en/news-insights/trending/IdWDCYtwerAXFMxBxBV6GQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

PTC Therapeutics chief commercial officer stepping down

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


PTC Therapeutics chief commercial officer stepping down

Mark Rothera agreed to step down as chief commercial officer of PTC Therapeutics Inc., effective Aug. 9.

Rothera entered into a consulting agreement, effective Aug. 10, 2017, with a term continuing through Sept. 30, 2018.